首页> 外文OA文献 >A cost-utility analysis of SIR-Spheres Y-90 resin microspheres versus best supportive care in the treatment of unresectable metastatic colorectal cancer refractory to chemotherapy in the UK

【2h】

A cost-utility analysis of SIR-Spheres Y-90 resin microspheres versus best supportive care in the treatment of unresectable metastatic colorectal cancer refractory to chemotherapy in the UK

机译：先生球体Y-90树脂微球的成本实用性分析与英国化疗未切除的转移性结直肠癌难治性的最佳支持性护理

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
V. K. Brennan; F. Colaone; S. Shergill; R. F. Pollock;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer. [J] . Van-Cutsem E, Peeters M, Siena S, Journal of Clinical Oncology . 2007,第13期

机译：在化疗难治性转移性结直肠癌患者中，帕尼单抗联合最佳支持治疗与单独最佳支持治疗的开放标签III期试验。
2. Radioembolization with 90 Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a prospective pilot study [J] . Nicholas Fidelman, Robert K. Kerlan Jr, Randall A. Hawkins, Journal of Gastrointestinal Oncology . 2016,第6期

机译：90 Y玻璃微球体的放射栓塞治疗无法治愈的化疗难治性胃肠道癌转移性肝病：一项前瞻性试验研究的最终报告
3. 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: A pilot study [J] . FidelmanN., KerlanJr.R.K., HawkinsR.A., Journal of gastrointestinal cancer. . 2014,第2期

机译：90Y玻璃微球用于治疗难治性胃肠道癌引起的不可切除的转移性肝病：一项初步研究
4. Development of dose response to Y-90 microsphere treatment of metastatic liver cancer by quantitative analysis of SPECT and PET images . [D] . Campbell, Janice M. 2008

机译：通过SPECT和PET图像定量分析建立Y-90微球治疗转移性肝癌的剂量反应。
5. Cost-effectiveness analysis of cetuximab/irinotecan vs active/best supportive care for the treatment of metastatic colorectal cancer patients who have failed previous chemotherapy treatment [O] . N Starling, D Tilden, J White, 2007

机译：西妥昔单抗/伊立替康与主动/最佳支持治疗对先前化疗无效的转移性结直肠癌患者的成本效益分析
6. PCN98 Selective Internal Radiotherapy (SIRT) Using Resin Yttrium-90 Microspheres for Chemotherapy-Refractory Metastatic Colorectal Cancer: An Italian Cost-Effectiveness Analysis [O] . Cosimelli M., Golfieri R., Pennington B., 2013

机译：使用树脂钇90微球的PCN98选择性内部放疗（SIRT）用于难治性转移性结直肠癌的化疗：意大利的成本-效果分析
7. Evaluation of Best Supportive Care and Systemic Chemotherapy as Treatment Stratified According to the Retrospective Peritoneal Surface Disease Severity Score (PSDSS) for Peritoneal Carcinomatosis of Colorectal Origin [R] . Pelz, J. O., Chua, T. C., Esquivel, J., 2010

机译：评估最佳支持治疗和全身化疗作为治疗分层根据回顾性腹膜表面疾病严重程度评分（psDss）的腹膜癌结直肠来源

A cost-utility analysis of SIR-Spheres Y-90 resin microspheres versus best supportive care in the treatment of unresectable metastatic colorectal cancer refractory to chemotherapy in the UK

著录项

引文网络

相似文献

相关主题

期刊订阅